Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer

Journal of Clinical Oncology

Volumn 17, Issue 3, 1999, Pages 870-879

  Slade, Martin J ^a   Smith, Brendan M ^a   Dudley Sinnett, H ^a   Cross, Nicholas C P ^a   Charles Coombes, R ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD; BONE MARROW; BREAST CANCER; CANCER GROWTH; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INTERMETHOD COMPARISON; METASTASIS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033051579     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.3.870     Document Type: Article

References (26)

1. Coombes RC, Powles TJ: Tests for distant metastases in patients with breast cancer. J R Soc Med 73:617-623, 1980
2. Mansi JL, Easton D, Berger U, et al: Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-up. Eur J Cancer 27:1552-1555, 1991
3. Coombes RC, Berger U, Mansi J, et al: Prognostic significance of micrometastases in bone marrow in patients with primary breast cancer. NCI Monogr 1:51-53, 1986
4. Diel I, Kaufmann M, Krempien B, et al: Immunocytochemical detection of tumour cells in bone marrow in patients with primary breast cancer. Br J Cancer 62:3A, 1990 (abstr)
5. Ellis G, Ferguson M, Yamanaka E, et al: Monoclonal antibodies for detection of occult carcinoma cells in bone marrow of breast cancer patients. Cancer 63:2509-2514, 1989
6. Osborne MP, Wong GY, Asina S, et al: Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow. Cancer Res 51:2706-2709, 1991
7. Schoenfeld A, Luqmani Y, Sinnett HD, et al: Keratin 19 mRNA measurement to detect micrometastases in lymph nodes in breast cancer patients. Br J Cancer 74:1639-1642, 1996
8. Zippelius A, Kufer P, Honold G, et al: Limitations of reverse transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol 15:2701-2708, 1997
9. Cross NCP, Lin F, Chase A, et al: Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 82:1929-1936, 1993
10. Lin F, van Rhee F, Goldman JM, et al: Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation. Blood 87:4473-4478, 1996
11. Hochhaus A, Lin F, Reiter A, et al: Quantification of residual disease in chronic myelogenous leukemia patients on interferon alfa therapy by competitive polymerase chain reaction. Blood 87:1549-1555, 1996
12. Cross NCP, Hughes TP, Lin F, et al: Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: Correlation with acute graft-versus-host disease and relapse. Br J Haematol 84:67-74, 1993
13. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
14. Hochhaus A, Lin F, Reiter A, et al: Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon alpha. Br J Haematol 91:126-131, 1995
15. Pantel K, Schlimok G, Angstwurm M, et al: Methodological analysis of immunocytochemical screening for disseminated epithelial tumor markers in bone marrow. J Hematother 3:165-173, 1994
16. Datta YH, Adams PT, Drobyski WR, et al: Sensitive detection of occult breast cancer by the reverse transcriptase polymerase chain reaction. J Clin Oncol 12:475-482, 1994
17. Schoenfeld A, Luqmani Y, Smith D, et al: Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 54:2986-2990, 1994
18. Burchull SA, Bradbury MF, Pittman K, et al: Detection of epithelial cancer cells in peripheral blood by reverse transcriptase polymerase chain reaction. Br J Cancer 71:278-281, 1995
19. Gunn J, McCall JL, Yun K, et al: Detection of micrometastases in colorectal cancer patients by K19 and K20 by reverse transcriptase polymerase chain reaction. Lab Invest 75:611-616, 1996
20. Traweek ST, Liu J, Battifora H: Keratin gene expression in non-epithelial tissues: Detection with polymerase chain reaction. Am J Pathol 142:1111-1118, 1993
21. Krismann M, Todt B, Schroder J, et al: Low specificity of cytokeratin 19 reverse transcriptase polymerase chain reaction analysis for detection of hematogenous lung cancer dissemination. J Clin Oncol 13:2769-2775, 1995
22. Bader BL, Jahn L, Franke WW: Low level expression of cytokeratins 8, 18 and 19 in vascular smooth muscle cells of human umbilical cord and in cultured cells derived therefrom, with an analysis of the chromosomal locus containing the cytokeratin 19 gene. Eur J Cell Biol 47:300-319, 1988
23. Schoenfeld A, Kruger KH, Gomm JJ, et al: The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and polymerase chain reaction for keratin 19. Eur J Cancer 33:854-861, 1997
24. DeVita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology (ed 3). Philadelphia, PA, Lippincott, 1989
25. Seckl MJ, Rustin GJS, Coombes RC: CA125 is not a reliable marker in metastatic breast cancer. Br J Cancer 66:875-876, 1992
26. Morgan GJ, Pratt G: Modern molecular diagnostics and the management of haematological malignancies. Clin Lab Haematol 20:135-141, 1998